Fundraising Fox
NanoVation Therapeutics
Vancouver, CA · 2 known investors
Find your way into NanoVation Therapeutics
Sign up to see every warm intro you have to NanoVation Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NanoVation Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NanoVation Therapeutics develops lipid nanoparticle (LNP) and mRNA delivery technologies for gene therapies, supporting drug development partners across mRNA synthesis, LNP formulation, and preclinical delivery optimization. It works with pharmaceutical and biotech partners on end-to-end gene therapy delivery.
Founders & leadership
DW
JK
ZJ
Zach Jonasson
DM
David Main
Investors · 2
In the news
Frequently asked questions
- What does NanoVation Therapeutics do?
- NanoVation Therapeutics develops lipid nanoparticle (LNP) and mRNA delivery technologies for gene therapies, supporting drug development partners across mRNA synthesis, LNP formulation, and preclinical delivery optimization. It works with pharmaceutical and biotech partners on end-to-end gene therapy delivery.
- Who founded NanoVation Therapeutics?
- NanoVation Therapeutics was founded by Pieter Cullis, Dominik Witzigmann, Jayesh Kulkarni, Zach Jonasson, David Main.
- Who are NanoVation Therapeutics's investors?
- NanoVation Therapeutics's investors include Convergent Ventures, Innovation UBC.
- Where is NanoVation Therapeutics headquartered?
- NanoVation Therapeutics is headquartered in Vancouver, CA.